Unity Biotechnology, INC Form 4 insider transactions

3 May 2024

UBX

Form 4: Unity Biotechnology CEO Anirvan Ghosh Sells Shares to Cover Tax Obligations

Anirvan Ghosh, CEO of Unity Biotechnology, sold 603 shares of common stock at $1.55 per share on May 2, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

27 Mar 2024

UBX

Unity Biotechnology, INC

Form 4: Unity Biotechnology Executive Alexander Nguyen Reports Stock and Option Awards

Alexander Hieu Nguyen, Chief Legal Officer of Unity Biotechnology, reports the acquisition of restricted stock units and stock options.